Global Industry Analysts, Inc., April 2010, Pages: 405
This report analyzes the Global market for PancreaticCancer Drugs in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 57 companies including Abraxis
Bioseeker, Feb 2011
"Analytical Tool - PancreaticCancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreaticcancer R&D and business development
Bioseeker, July 2011, Pages: 2592
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and PancreaticCancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, Oct 2010, Pages: 2182
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and PancreaticCancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, March 2011, Pages: 2325
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and PancreaticCancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three
Bioseeker, Oct 2010, Pages: 2107
This triple analysis focuses on cancer drug development strategies in both PancreaticCancer and Prostate Cancer and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual
Bioseeker, July 2011, Pages: 2846
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and PancreaticCancer. Each of these three individual parts is evaluated according to standardized
Bioseeker, July 2011, Pages: 2989
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and PancreaticCancer. Each of these three individual parts is evaluated according
Bioseeker, July 2011, Pages: 2771
This triple analysis focuses on cancer drug development strategies in Lung Cancer, PancreaticCancer and Prostate Cancer. Each of these three individual parts is evaluated according to standardized
Bioseeker, March 2011, Pages: 2579
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Colorectal Cancer and PancreaticCancer. Each of these three individual parts is evaluated according
Bioseeker, Sep 2011, Pages: 3213
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (PancreaticCancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific
Bioseeker, May 2010, Pages: 2361
This triple analysis focuses on cancer drug development strategies in Breast Cancer, PancreaticCancer and Prostate Cancer. Each of these three individual parts is evaluated according
Bioseeker, March 2011, Pages: 2504
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, PancreaticCancer and Prostate Cancer. Each of these three individual parts is evaluated according
Bioseeker, Nov 2011, Pages: 2175
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (PancreaticCancer), one mechanism/target/effect area (Cancer Vaccines) and one compound specific
Bioseeker, Dec 2011, Pages: 2886
This triple analysis focuses on cancer drug development strategies in PancreaticCancer and by the two mechanism/target/effect areas of Apoptosis and Cancer Vaccines. Each of these three individual
Bioseeker, Jan 2012, Pages: 2973
This triple analysis focuses on cancer drug development strategies in PancreaticCancer and by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines. Each of these three
Bioseeker, Sep 2011, Pages: 3877
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and PancreaticCancer and by the compound strategy of Antibodies. Each of these three individual parts
Bioseeker, Dec 2011, Pages: 3550
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and PancreaticCancer and by the mechanism/target/effect of Apoptosis. Each of these three individual parts
Bioseeker, Jan 2012, Pages: 3637
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and PancreaticCancer and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts
Bioseeker, Nov 2011, Pages: 2839
This triple analysis focuses on cancer drug development strategies in both Lung Cancer and PancreaticCancer and by the compound strategy of Peptides. Each of these three individual parts